Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection

[1]  C. Reis,et al.  Gastric cancer: Basic aspects , 2018, Helicobacter.

[2]  L. Helyer,et al.  Evaluating TNM stage prognostic ability in a population-based cohort of gastric adenocarcinoma patients in a low-incidence country , 2018, Canadian Journal of Public Health.

[3]  S. Cai,et al.  External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China. , 2018, Surgical oncology.

[4]  J. Ajani,et al.  Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database , 2017, Annals of Surgical Oncology.

[5]  H. Seo,et al.  Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea , 2017, Journal of gastric cancer.

[6]  W. Jia,et al.  Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers , 2017, International journal of cancer.

[7]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[8]  M. Ricco’,et al.  Prognostic assessment of gastric cancer: retrospective analysis of two decades. , 2016, Acta bio-medica : Atenei Parmensis.

[9]  K. Ishii,et al.  [Epidemiology of hepatitis A virus]. , 2015, Nihon rinsho. Japanese journal of clinical medicine.

[10]  Y. Zeng,et al.  Hepatitis B Virus Infection and Risk of Nasopharyngeal Carcinoma in Southern China , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[11]  R. Xu,et al.  Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases , 2015, British Journal of Cancer.

[12]  H. Liang,et al.  Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. , 2014, World journal of gastroenterology.

[13]  Sheng-Nan Lu,et al.  Prediction models of long‐term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles , 2013, Hepatology.

[14]  C. Varon,et al.  Gastric cancer: Basic aspects , 2012, Helicobacter.

[15]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[16]  A. Ristimäki,et al.  Gastric Cancer: Basic Aspects , 2011, Helicobacter.

[17]  Rajiv Jalan,et al.  Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[18]  M. Dehesa-Violante,et al.  Epidemiology of hepatitis virus B and C. , 2007, Archives of medical research.

[19]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[21]  C. Hassan,et al.  Gastric cancer prevalence in patients with liver cirrhosis , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  B. Zilberstein,et al.  Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  H. Zeng,et al.  Does HBV infection increase risk of endometrial carcinoma? , 2014, Asian Pacific journal of cancer prevention : APJCP.

[24]  W. Beil,et al.  Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis. , 2011, International journal of clinical and experimental medicine.

[25]  S. Eser,et al.  Cancer epidemiology and control in North-Western and Central Asia - past, present and future. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[26]  W J Mackillop,et al.  Measuring the accuracy of prognostic judgments in oncology. , 1997, Journal of clinical epidemiology.